drugset / Trial / NCT04357015

Intravenous Tranexamic Acid Versus IV Carbetocin in Abdominal Myomectomy

NCT04357015

Phase 4 Unknown 153 enrolled Cairo University
RandomizedParallel-groupQuadruple-blindPrevention

Summary

the aim of the present study is to compare safety and efficacy of intravenous tranexamic acid versus IV carbetocin in reducing blood loss during abdominal myomectomy: a randomized controlled trial

Timeline

Start
2020-05-01
Primary completion
2020-10-10
Completion
2020-10-20

Drugs

EvaluationDrugModalityDoseRoute
Comparator Carbetocin Peptide 100 ug Intravenous
Subject Tranexamic Acid Small molecule 15 mg/kg Intravenous

Indications